Private costs almost equal health care costs when intervening in mild Alzheimer's: a cohort study alongside the DAISY trial

<p>Abstract</p> <p>Background</p> <p>Alzheimer's disease is the leading cause of dementia and affects about 25 million people worldwide. Recent studies have evaluated the effect of early interventions for dementia, but few studies have considered private time and t...

Full description

Bibliographic Details
Main Authors: Waldorff Frans, Eckermann Ane, Buss Dorthe, Waldemar Gunhild, S&#248;gaard Rikke, S&#248;rensen Jan
Format: Article
Language:English
Published: BMC 2009-01-01
Series:BMC Health Services Research
Online Access:http://www.biomedcentral.com/1472-6963/9/215
id doaj-90fe9641f126460997664cee17baa13b
record_format Article
spelling doaj-90fe9641f126460997664cee17baa13b2020-11-25T00:15:09ZengBMCBMC Health Services Research1472-69632009-01-0191215Private costs almost equal health care costs when intervening in mild Alzheimer's: a cohort study alongside the DAISY trialWaldorff FransEckermann AneBuss DortheWaldemar GunhildS&#248;gaard RikkeS&#248;rensen Jan<p>Abstract</p> <p>Background</p> <p>Alzheimer's disease is the leading cause of dementia and affects about 25 million people worldwide. Recent studies have evaluated the effect of early interventions for dementia, but few studies have considered private time and transportation costs associated with the intervention. This study assessed the total economic costs associated with a multifaceted intervention for mild Alzheimer's disease, including an estimate of the ratio of public to private costs.</p> <p>Methods</p> <p>The study sample comprised 163 dyads of patients and caregivers who received a multifaceted intervention of counselling sessions, courses and informational packages. The typical duration of the intervention was 7 months. A micro-costing approach was applied using prospectively collected data on resource utilisation that included estimates of participant time and transportation. Precision estimates were calculated using a bootstrapping technique and structural uncertainty was assessed with sensitivity analysis.</p> <p>Results</p> <p>The direct intervention cost was estimated at EUR 1,070 (95% CI 1,029;1,109). The total cost (including private costs) was estimated at EUR 2,020 (95% CI 1,929;2,106) i.e. the ratio of private to public costs was almost 1:1.</p> <p>Conclusion</p> <p>Intervention for mild Alzheimer's disease can be undertaken at a relatively low cost to public funds. However, policy planners should pay attention to the significant private costs associated with an intervention, which may ultimately pose a threat to equity in access to health care.</p> <p>Trial registration</p> <p>Current Controlled Trials ISRCTN74848736.</p> http://www.biomedcentral.com/1472-6963/9/215
collection DOAJ
language English
format Article
sources DOAJ
author Waldorff Frans
Eckermann Ane
Buss Dorthe
Waldemar Gunhild
S&#248;gaard Rikke
S&#248;rensen Jan
spellingShingle Waldorff Frans
Eckermann Ane
Buss Dorthe
Waldemar Gunhild
S&#248;gaard Rikke
S&#248;rensen Jan
Private costs almost equal health care costs when intervening in mild Alzheimer's: a cohort study alongside the DAISY trial
BMC Health Services Research
author_facet Waldorff Frans
Eckermann Ane
Buss Dorthe
Waldemar Gunhild
S&#248;gaard Rikke
S&#248;rensen Jan
author_sort Waldorff Frans
title Private costs almost equal health care costs when intervening in mild Alzheimer's: a cohort study alongside the DAISY trial
title_short Private costs almost equal health care costs when intervening in mild Alzheimer's: a cohort study alongside the DAISY trial
title_full Private costs almost equal health care costs when intervening in mild Alzheimer's: a cohort study alongside the DAISY trial
title_fullStr Private costs almost equal health care costs when intervening in mild Alzheimer's: a cohort study alongside the DAISY trial
title_full_unstemmed Private costs almost equal health care costs when intervening in mild Alzheimer's: a cohort study alongside the DAISY trial
title_sort private costs almost equal health care costs when intervening in mild alzheimer's: a cohort study alongside the daisy trial
publisher BMC
series BMC Health Services Research
issn 1472-6963
publishDate 2009-01-01
description <p>Abstract</p> <p>Background</p> <p>Alzheimer's disease is the leading cause of dementia and affects about 25 million people worldwide. Recent studies have evaluated the effect of early interventions for dementia, but few studies have considered private time and transportation costs associated with the intervention. This study assessed the total economic costs associated with a multifaceted intervention for mild Alzheimer's disease, including an estimate of the ratio of public to private costs.</p> <p>Methods</p> <p>The study sample comprised 163 dyads of patients and caregivers who received a multifaceted intervention of counselling sessions, courses and informational packages. The typical duration of the intervention was 7 months. A micro-costing approach was applied using prospectively collected data on resource utilisation that included estimates of participant time and transportation. Precision estimates were calculated using a bootstrapping technique and structural uncertainty was assessed with sensitivity analysis.</p> <p>Results</p> <p>The direct intervention cost was estimated at EUR 1,070 (95% CI 1,029;1,109). The total cost (including private costs) was estimated at EUR 2,020 (95% CI 1,929;2,106) i.e. the ratio of private to public costs was almost 1:1.</p> <p>Conclusion</p> <p>Intervention for mild Alzheimer's disease can be undertaken at a relatively low cost to public funds. However, policy planners should pay attention to the significant private costs associated with an intervention, which may ultimately pose a threat to equity in access to health care.</p> <p>Trial registration</p> <p>Current Controlled Trials ISRCTN74848736.</p>
url http://www.biomedcentral.com/1472-6963/9/215
work_keys_str_mv AT waldorfffrans privatecostsalmostequalhealthcarecostswheninterveninginmildalzheimersacohortstudyalongsidethedaisytrial
AT eckermannane privatecostsalmostequalhealthcarecostswheninterveninginmildalzheimersacohortstudyalongsidethedaisytrial
AT bussdorthe privatecostsalmostequalhealthcarecostswheninterveninginmildalzheimersacohortstudyalongsidethedaisytrial
AT waldemargunhild privatecostsalmostequalhealthcarecostswheninterveninginmildalzheimersacohortstudyalongsidethedaisytrial
AT s248gaardrikke privatecostsalmostequalhealthcarecostswheninterveninginmildalzheimersacohortstudyalongsidethedaisytrial
AT s248rensenjan privatecostsalmostequalhealthcarecostswheninterveninginmildalzheimersacohortstudyalongsidethedaisytrial
_version_ 1725388450947923968